Syneos Health and Aetion Partner to Offer RWE Solutions to Advance Drug Development and Commercialization
August 02, 2021 07:00 ET
|
Syneos Health, Inc.
MORRISVILLE, N.C. and NEW YORK, Aug. 02, 2021 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH) and Aetion® announced a partnership to provide regulatory-grade data and analytics-driven solutions to...
Syneos Health Names Michael Brooks Chief Development Officer
July 14, 2021 08:00 ET
|
Syneos Health, Inc.
MORRISVILLE, N.C., July 14, 2021 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced the appointment of Michael...
Syneos Health Schedules Second Quarter 2021 Earnings Call for Monday, August 9, 2021
July 12, 2021 16:05 ET
|
Syneos Health, Inc.
MORRISVILLE, N.C., July 12, 2021 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, will release its second quarter 2021 financial...
Dr. David S. Wilkes Appointed to Syneos Health Board of Directors
June 16, 2021 07:00 ET
|
Syneos Health, Inc.
MORRISVILLE, N.C., June 16, 2021 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced the appointment of David S....
Syneos Health Launches “Lab to Life” Enterprise Partnership with Komodo Health
May 03, 2021 07:00 ET
|
Syneos Health, Inc.
MORRISVILLE, N.C., May 03, 2021 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, announced today it has expanded its relationship...
Illingworth Research Group Recognized with Queen’s Award for Enterprise: International Trade 2021
April 30, 2021 05:05 ET
|
Syneos Health, Inc.
MORRISVILLE, N.C., April 30, 2021 (GLOBE NEWSWIRE) -- The Illingworth Research Group, a Syneos Health® company, has been recognized with a 2021 Queen’s Award for Enterprise for International Trade....
Syneos Health Reports First Quarter 2021 Results
April 29, 2021 06:16 ET
|
Syneos Health, Inc.
Highlights Revenue of $1,208.7 million for the three months ended March 31, 2021, representing a sequential increase of 6.0% compared to the three months ended December 31, 2020, and a...
Syneos Health Announces Pricing of Secondary Offering of Common Stock
March 01, 2021 09:28 ET
|
Syneos Health, Inc.
MORRISVILLE, N.C., March 01, 2021 (GLOBE NEWSWIRE) -- Syneos Health, Inc. (Nasdaq: SYNH) (the “Company” or “Syneos Health”), the only fully integrated biopharmaceutical solutions organization...
Syneos Health Schedules Fourth Quarter and Full Year 2020 Earnings Call for Thursday, February 18, 2021
January 26, 2021 18:37 ET
|
Syneos Health, Inc.
MORRISVILLE, N.C., Jan. 26, 2021 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, will release its fourth quarter and full year...
Syneos Health to Present at the 39th Annual J.P. Morgan Healthcare Conference
January 04, 2021 16:15 ET
|
Syneos Health, Inc.
MORRISVILLE, N.C., Jan. 04, 2021 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization combining a CRO (Contract Research Organization)...